We are live on
!
Find out more
CCM
Cadence Capital Management Portfolio holdings
AUM
$415M
1-Year Est. Return
11.01%
This Fund
S&P 500
This Quarter
Est. Return
+5.02%
1 Year Est. Return
-11.01%
3 Year Est. Return
+0.72%
5 Year Est. Return
+39.08%
10 Year Est. Return
–
AUM
$2.09B
AUM Growth
-$289M
(-12%)
Cap. Flow
-$380M
Cap. Flow
% of AUM
-18.22%
Top 10 Holdings %
Top 10 Hldgs %
8.31%
Holding
697
New
113
Increased
76
Reduced
358
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Bancorp
USB
|
+$11.6M |
| 2 |
Phillips 66
PSX
|
+$11.1M |
| 3 |
MetLife
MET
|
+$10.1M |
| 4 |
Macy's
M
|
+$9.08M |
| 5 |
O'Reilly Automotive
ORLY
|
+$8.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$17.7M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$10.7M |
| 3 |
GAP
The Gap Inc
GAP
|
+$8.4M |
| 4 |
United Airlines
UAL
|
+$8.14M |
| 5 |
SKX
Skechers
SKX
|
+$7.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.17% |
| 2 | Industrials | 14.75% |
| 3 | Technology | 13.58% |
| 4 | Healthcare | 12.19% |
| 5 | Financials | 10.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Littelfuse
LFUS
$11.2B
| $4.66M | 0.22% |
50,162
-18,902
| -27% | -$1.73M |
|
|
SGNT
152
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $4.65M | 0.22% |
+179,830
| New | +$3.99M |
|
153
Home BancShares
HOMB
$6.25B
| $4.63M | 0.22% |
282,364
-26,124
| -8% | -$421K |
|
|
SYKE
154
DELISTED
SYKES Enterprises Inc
SYKE
| $4.63M | 0.22% |
212,866
-84,085
| -28% | -$1.71M |
|
|
HZNP
155
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $4.62M | 0.22% |
292,090
-91,700
| -24% | -$1.31M |
|
156
Graphic Packaging
GPK
$3.24B
| $4.6M | 0.22% |
393,469
-152,782
| -28% | -$1.64M |
|
|
SNCR
157
DELISTED
Synchronoss Technologies
SNCR
| $4.6M | 0.22% |
14,626
-5,717
| -28% | -$1.64M |
|
|
VRNT
158
DELISTED
Verint Systems
VRNT
| $4.6M | 0.22% |
+183,927
| New | +$4.33M |
|
159
Old Dominion Freight Line
ODFL
$44.2B
| $4.59M | 0.22% |
216,420
-30,000
| -12% | -$605K |
|
160
Molina Healthcare
MOH
$10.2B
| $4.56M | 0.22% |
102,261
-39,683
| -28% | -$1.61M |
|
161
Crane NXT
CXT
$2.97B
| $4.54M | 0.22% |
+175,964
| New | +$4.44M |
|
162
Stryker
SYK
$133B
| $4.53M | 0.22% |
53,764
-18,950
| -26% | -$1.55M |
|
163
Tapestry
TPR
$30.8B
| $4.53M | 0.22% |
132,458
+7,043
| +6% | +$302K |
|
164
Pegasystems
PEGA
$4.94B
| $4.5M | 0.22% |
426,194
+11,722
| +3% | +$112K |
|
165
J&J Snack Foods
JJSF
$1.44B
| $4.48M | 0.21% |
47,594
-18,456
| -28% | -$1.74M |
|
|
WBMD
166
DELISTED
WebMD Health Corp.
WBMD
| $4.48M | 0.21% |
92,696
-36,239
| -28% | -$1.58M |
|
167
Ubiquiti
UI
$32.3B
| $4.46M | 0.21% |
+98,660
| New | +$3.87M |
|
168
Healthcare Services Group
HCSG
$1.58B
| $4.44M | 0.21% |
150,871
-59,326
| -28% | -$1.75M |
|
169
Starbucks
SBUX
$121B
| $4.44M | 0.21% |
114,774
-41,104
| -26% | -$1.49M |
|
|
B
170
DELISTED
Barnes Group Inc.
B
| $4.44M | 0.21% |
115,102
-44,829
| -28% | -$1.71M |
|
171
Dover
DOV
$27.5B
| $4.43M | 0.21% |
60,365
-8,913
| -13% | -$623K |
|
172
Globus Medical
GMED
$10.9B
| $4.42M | 0.21% |
184,792
-72,615
| -28% | -$1.75M |
|
173
Evercore
EVR
$12.1B
| $4.4M | 0.21% |
76,263
-29,638
| -28% | -$1.63M |
|
|
SWFT
174
DELISTED
Swift Transportation Company
SWFT
| $4.39M | 0.21% |
173,907
-68,983
| -28% | -$1.67M |
|
|
IRF
175
DELISTED
INTL RECTIFIER CORP
IRF
| $4.37M | 0.21% |
156,758
-61,012
| -28% | -$1.64M |
|
Similar funds
MGAI
FA
LWS
VCP
AIM
F
CPF
IA
Cadence Capital Management's Q2 2014 Portfolio in Review
As of Q2 2014, Cadence Capital Management held 697 positions worth $2.09B, down 12% from $2.37B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
Cadence Capital Management withdrew a net $380M in Q2 2014, closing 150 positions and reducing 358 holdings. Its most notable exit was Alnylam Pharmaceuticals, an estimated $10.7M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 13% a quarter earlier, followed by Industrials and Technology.
Against the trend, Cadence Capital Management opened a new position in US Bancorp worth $12.1M.
- Cadence Capital Management's largest Q2 2014 buy was US Bancorp: 279,044 shares worth $12.1M.
- Cadence Capital Management added most to Wynn Resorts in Q2 2014, an estimated $7.23M increase.
- Cadence Capital Management's biggest Q2 2014 reduction was Apple, cutting an estimated $17.7M.
- Cadence Capital Management fully exited Alnylam Pharmaceuticals in Q2 2014, selling an estimated $10.7M.
- Cadence Capital Management's ten largest holdings make up 8.3% of its $2.09B portfolio in Q2 2014.
- Cadence Capital Management opened 113 new positions and closed 150 in Q2 2014.
- Cadence Capital Management's portfolio value fell 12% quarter-over-quarter to $2.09B.
Based on Cadence Capital Management's 13F filing for Q2 2014, filed 23 Jul 2014.